Agmatinase Antibodies

Santa Cruz Biotechnology features a diverse variety of Agmatinase monoclonal antibodies for various research applications. Agmatinase monoclonal antibodies are compatible with western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Agmatinase, an enzyme involved in the metabolism of agmatine, plays a crucial role in the urea cycle and influences various physiological processes, including neurotransmission and cell signaling. Research has shown that agmatinase activity significantly impacts neurological function and metabolic regulation. Understanding agmatinase expression patterns and interactions provides valuable insights into potential therapeutic strategies for neurological disorders and metabolic diseases. Investigating agmatinase mechanisms helps reveal its role in cellular homeostasis and physiological adaptation. Ongoing studies continue to uncover new aspects of agmatinase function in health and disease. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific knowledge and contribute to breakthrough discoveries in agmatinase research.